Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Noora Puhakka"'
Autor:
Roxanne Aniceto, Denes V. Agoston, Gregory Smith, Pedro Andrade de Abreu, Terence J. O'Brien, Matthew R. Hudson, Shalini Das Gupta, Pablo M. Casillas-Espinosa, Alaa Kamnaksh, Xavier Ekolle Ndode-Ekane, Sandy R. Shultz, Rhys D. Brady, Riikka Immonen, Jesse Mccullough, Noora Puhakka, Idrish Ali, Asla Pitkänen, Richard J. Staba, César Emmanuel Santana-Gómez, Nigel C. Jones
Publikováno v:
Epilepsy Research. 149:92-101
The Epilepsy Bioinformatics Study for Antiepileptogenic Therapy (EpiBioS4Rx) is an international, multicenter, multidisciplinary study aimed at preventing epileptogenesis (EpiBioS4Rx: https://epibios.loni.usc.edu/). One of the study's major objective
Autor:
Tomi Paananen, Elina Hämäläinen, Asla Pitkänen, Noora Puhakka, Niina Lapinlampi, Xavier Ekolle Ndode-Ekane, Pedro Andrade
Publikováno v:
EpilepsiaREFERENCES. 61(9)
OBJECTIVE To identify postinjury physiologic, behavioral, and cognitive biomarkers for posttraumatic epilepsy to enrich study populations for long-term antiepileptogenesis studies. METHODS The EPITARGET cohort with behavioral follow-up and 1-month 24
Autor:
Robert Ciszek, Natallie Kajevu, Xavier Ekolle Ndode-Ekane, Jenni Kyyriäinen, Shalini Das Gupta, Mette Heiskanen, Tomi Paananen, Asla Pitkänen, Leonardo Lara-Valderrábano, Niina Lapinlampi, Niina Vuokila, Pedro Andrade, Noora Puhakka, Ivette Bañuelos-Cabrera
Publikováno v:
Epilepsybehavior : EB. 121
A biomarker is a characteristic that can be objectively measured as an indicator of normal biologic processes, pathogenic processes, or responses to an exposure or intervention, including therapeutic interventions. Biomarker modalities include molecu
Autor:
Gregory Smith, Idrish Ali, Richard J. Staba, César Emmanuel Santana-Gómez, Rhys D. Brady, Emma L. Braine, Tomi Paananen, Pedro Andrade, Riikka Immonen, Xavier Ekolle Ndode-Ekane, Noora Puhakka, Matthew R. Hudson, Jussi Tohka, Pablo M. Casillas-Espinosa, Terence J. O'Brien, Sandy R. Shultz, Robert Ciszek, Nigel C. Jones, Asla Pitkänen, Piero Perucca
Publikováno v:
Epilepsy Res
Rationale The Epilepsy Bioinformatics Study for Antiepileptogenic Therapy (EpiBioS4Rx) Centre without walls is an NIH funded multicenter consortium. One of EpiBioS4Rx projects is a preclinical post-traumatic epileptogenesis biomarker study that invol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f31fe9664ccc8ded3340863076b0b59
https://escholarship.org/uc/item/2w8178fh
https://escholarship.org/uc/item/2w8178fh
Autor:
Matthew R. Hudson, Noora Puhakka, Alaa Kamnaksh, Pablo M. Casillas-Espinosa, Richard J. Staba, Robert Ciszek, Terence J. O'Brien, Tomi Paananen, Rhys D. Brady, Cesar Santana Gomez, Jussi Tohka, Pedro Andrade, Asla Pitkänen, Xavier Ekolle Ndode-Ekane, Niina Lapinlampi, Gregory Smith, Idrish Ali, Sandy R. Shultz, Riikka Immonen
Publikováno v:
Epilepsy research. 150
The Epilepsy Bioinformatics Study for Antiepileptogenic Therapy (EpiBioS4Rx) is a National Institutes for Neurological Diseases and Stoke funded Centers-Without-Walls international multidisciplinary study aimed at preventing epileptogenesis. The prec
Autor:
Matthew R. Hudson, Noora Puhakka, Riikka Immonen, Emma L. Braine, Gregory Smith, Xavier Ekolle Ndode-Ekane, Richard J. Staba, César Emmanuel Santana-Gómez, Rhys D. Brady, Idrish Ali, Asla Pitkänen, Pedro Andrade, Pablo M. Casillas-Espinosa, Terence J. O'Brien, Sandy R. Shultz
Publikováno v:
Epilepsy research. 151
Multi-center preclinical studies can facilitate the discovery of biomarkers of antiepileptogenesis and thus facilitate the diagnosis and treatment development of patients at risk of developing post-traumatic epilepsy. However, these studies are often
Publikováno v:
Epilepsy & Behavior. 51:19-27
Several components of the urokinase-type plasminogen activator receptor (uPAR)-interactome, including uPAR and its ligand sushi-repeat protein 2, X-linked (SRPX2), are linked to susceptibility to epileptogenesis in animal models and/or humans. Recent
Autor:
Idrish Ali, Gregory Smith, Terence J. O'Brien, Pablo M. Casillas-Espinosa, Sandy R. Shultz, Richard J. Staba, Tomi Paananen, Asla Pitkänen, César Emmanuel Santana-Gómez, Nigel C. Jones, Piero Perucca, Matthew R. Hudson, Noora Puhakka, Pedro Andrade, Robert Ciszek, Xavier Ekolle Ndode-Ekane, Brian K. Rundle, Rhys D. Brady, Riikka Immonen
Publikováno v:
Epilepsy Res
Studies of chronic epilepsy show pathological high frequency oscillations (HFOs) are associated with brain areas capable of generating epileptic seizures. Only a few of these studies have focused on HFOs during the development of epilepsy, but result
Publikováno v:
Neurobiology of Disease, Vol 123, Iss, Pp 42-58 (2019)
A biomarker is a characteristic that is measured as an indicator of normal biologic processes, pathogenic processes, or responses to an exposure or intervention, including therapeutic interventions. Biomarker modalities include molecular, histologic,
Publikováno v:
Epilepsybehavior : EB. 60
Binding of the extracellular matrix proteinase urokinase-type plasminogen activator (uPA) to its receptor, uPAR, regulates tissue remodeling during development and after injury in different organs, including the brain. Accordingly, mutations in the P